Skip to content

Corbus Pharmaceuticals Holdings, Inc.: 10-Q filed 2015-08-13

What Corbus Pharmaceuticals Holdings, Inc. reported in its quarterly report filed 2015-08-13 (fiscal Q2 2015): 26 published measures, 68 facts as tagged in accession 0001193125-15-289161.

This filing

Form
10-Q (quarterly report)
Filed
2015-08-13
Fiscal period
fiscal Q2 2015
Accession
0001193125-15-289161 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Corbus Pharmaceuticals Holdings, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-06-309,564,751USD
At 2014-12-316,600,773USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-06-302,795,615USD
At 2014-12-31593,651USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-06-306,769,136USD
At 2014-12-315,862,733USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-06-309,243,153USD
At 2014-12-316,262,445USD
At 2014-06-308,504,172USD
At 2013-12-31303,020USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-2,562,541USD91
2015-01-01 to 2015-06-30-4,098,259USD181
2014-04-01 to 2014-06-30-504,608USD91
2014-01-01 to 2014-06-30-620,587USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-06-3016,222USD181
2014-01-01 to 2014-06-308,009USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-04-01 to 2015-06-30113,636USD91
2015-01-01 to 2015-06-30113,636USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-06-30-8,525,334USD
At 2014-12-31-4,427,075USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-06-3058,725USD
At 2014-12-3154,044USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-01-01 to 2015-06-30602,863USD181
2014-01-01 to 2014-06-3026,412USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-2,562,696USD91
2015-01-01 to 2015-06-30-4,097,995USD181
2014-04-01 to 2014-06-30-464,297USD91
2014-01-01 to 2014-06-30-569,942USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-06-309,492,296USD
At 2014-12-316,533,001USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-04-01 to 2015-06-30393USD91
2015-01-01 to 2015-06-301,372USD181
2014-04-01 to 2014-06-3011,232USD91
2014-01-01 to 2014-06-3022,395USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-06-302,340,867USD
At 2014-12-31593,651USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-06-301,069,213USD
At 2014-12-31344,160USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-04-01 to 2015-06-302,676,332USD91
2015-01-01 to 2015-06-304,211,631USD181
2014-04-01 to 2014-06-30464,297USD91
2014-01-01 to 2014-06-30569,942USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-04-01 to 2015-06-301,707,256USD91
2015-01-01 to 2015-06-302,430,686USD181
2014-04-01 to 2014-06-30169,443USD91
2014-01-01 to 2014-06-30231,360USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-06-3030,745,627shares
At 2014-12-3125,938,332shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-06-3015,291,395USD
At 2014-12-3110,287,214USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-06-3021,946USD
At 2014-12-3110,405USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2015-06-30390,038USD
At 2014-12-31249,491USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30969,076USD91
2015-01-01 to 2015-06-301,780,945USD181
2014-04-01 to 2014-06-30294,854USD91
2014-01-01 to 2014-06-30338,582USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2015-01-01 to 2015-06-3011,541USD181
2014-01-01 to 2014-06-30180USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-04-01 to 2015-06-30155USD91
2015-01-01 to 2015-06-30-264USD181
2014-04-01 to 2014-06-30-40,311USD91
2014-01-01 to 2014-06-30-50,645USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2015-01-01 to 2015-06-304,401,799USD181
2014-01-01 to 2014-06-308,670,824USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30925,053USD181
2014-01-01 to 2014-06-3027,193USD181

Inspect the source

Entity
Corbus Pharmaceuticals Holdings, Inc. / CIK 0001595097
Captured
2026-09-20T09:24:35.285Z
SEC response SHA-256
946cd75b294f9564550986f5a835381ea0b20b9b7c1140d70659a5c384e7d54a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001595097.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))